SRS Capital Advisors Inc. Has $168,000 Stake in STERIS plc (NYSE:STE)

SRS Capital Advisors Inc. raised its holdings in STERIS plc (NYSE:STE) by 74.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 764 shares of the medical equipment provider’s stock after acquiring an additional 325 shares during the period. SRS Capital Advisors Inc.’s holdings in STERIS were worth $168,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in STE. Millburn Ridgefield Corp acquired a new position in shares of STERIS during the third quarter worth about $25,000. Catalyst Capital Advisors LLC acquired a new position in shares of STERIS during the third quarter worth about $25,000. Global Wealth Management Investment Advisory Inc. acquired a new position in shares of STERIS during the third quarter worth about $49,000. NBC Securities Inc. acquired a new position in shares of STERIS during the third quarter worth about $50,000. Finally, Exchange Traded Concepts LLC acquired a new position in shares of STERIS during the third quarter worth about $54,000. 94.69% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on STE. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Friday, April 12th. KeyCorp initiated coverage on STERIS in a research report on Tuesday, February 6th. They set an “overweight” rating and a $253.00 price objective for the company. TheStreet upgraded STERIS from a “c+” rating to a “b” rating in a report on Wednesday, February 7th. StockNews.com lowered STERIS from a “buy” rating to a “hold” rating in a report on Friday. Finally, Stephens reiterated an “overweight” rating and set a $250.00 target price on shares of STERIS in a report on Friday, February 9th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, STERIS presently has an average rating of “Hold” and an average price target of $239.60.

STERIS Stock Performance

NYSE:STE traded up $1.58 on Friday, hitting $207.82. The company’s stock had a trading volume of 500,555 shares, compared to its average volume of 570,130. The company has a current ratio of 2.43, a quick ratio of 1.49 and a debt-to-equity ratio of 0.50. The stock has a fifty day moving average of $218.46 and a two-hundred day moving average of $216.18. The firm has a market capitalization of $20.53 billion, a P/E ratio of 36.40 and a beta of 0.81. STERIS plc has a one year low of $185.22 and a one year high of $254.00.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.17 by $0.05. The firm had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.35 billion. STERIS had a return on equity of 13.67% and a net margin of 10.48%. The business’s revenue for the quarter was up 14.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.02 earnings per share. Research analysts predict that STERIS plc will post 8.67 earnings per share for the current year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 12th will be paid a dividend of $0.52 per share. The ex-dividend date is Wednesday, June 12th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 1.00%. STERIS’s dividend payout ratio (DPR) is currently 36.43%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.